Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Finasteride affects prostate weights and pituitary activity differently with age.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Finasteride safely lowers DHT levels without affecting hormone levels, helping with conditions like enlarged prostate, acne, and hair loss.

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

All treatments helped with prostate symptoms, but the combination of dibenyline and finasteride worked best without extra side effects.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Patients follow treatment well, but many change medicines; good information helps compliance.